DOI:
10.1055/s-00000059
Pneumologie
LinksClose Window
References
Scagliotti GV, Hirsh V, Siena S. et al.
Overall survival improvement in patients with lung cancer and bone metastases treated with denosumab versus zoledronic acid: subgroup analysis from a randomized phase 3 study.
J Thorac Oncol 2012;
7: 1823-1829
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.